机构:[1]Key Laboratory of Medical Electrophysiology, Ministry of Education, School of Pharmacy of Southwest Medical University, Luzhou, China.[2]Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.[3]Central Nervous System Drug Key Laboratory of Sichuan Province, Southwest Medical University, Luzhou, China.[4]Department of Comprehensive Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.[5]Clinical Trial Center, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.[6]Department of Spinal Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.[7]Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, Institute of Medicinal Chemistry of Chinese Medicine, Chongqing Academy of Chinese MateriaMedica, Chongqing, China.[8]Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, United States.
This study was supported by the Cooperative Scientific
Research Project of Chunhui Plan of the Ministry of
Education of China (No. 2020-703), the Youth Science and
Technology Innovation Research Team (No. 2021JDTD0008),
and the Basic Research Fund (No. 2020YJ0336, 2020YJ0373) of
the Science and Technology Department of Sichuan province of
China, Science and Technology Innovation Team from
Jiucheng Science and Technology Talent Cultivation Plan in
Luzhou City (No. 2019-1), and Key Research and Development
Projectors of Office of Science & Technology and Talent Work
of Luzhou (No. 2021-SYF-26).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区医学
小类|3 区肿瘤学
最新[2023]版:
大类|3 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]Key Laboratory of Medical Electrophysiology, Ministry of Education, School of Pharmacy of Southwest Medical University, Luzhou, China.[2]Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.[3]Central Nervous System Drug Key Laboratory of Sichuan Province, Southwest Medical University, Luzhou, China.
共同第一作者:
通讯作者:
通讯机构:[1]Key Laboratory of Medical Electrophysiology, Ministry of Education, School of Pharmacy of Southwest Medical University, Luzhou, China.[2]Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.[3]Central Nervous System Drug Key Laboratory of Sichuan Province, Southwest Medical University, Luzhou, China.
推荐引用方式(GB/T 7714):
Zeng Mingtang,Pi Chao,Li Ke,et al.Patient-Derived Xenograft: A More Standard "Avatar" Model in Preclinical Studies of Gastric Cancer.[J].Frontiers in oncology.2022,12:898563.doi:10.3389/fonc.2022.898563.
APA:
Zeng Mingtang,Pi Chao,Li Ke,Sheng Lin,Zuo Ying...&Zhao Ling.(2022).Patient-Derived Xenograft: A More Standard "Avatar" Model in Preclinical Studies of Gastric Cancer..Frontiers in oncology,12,
MLA:
Zeng Mingtang,et al."Patient-Derived Xenograft: A More Standard "Avatar" Model in Preclinical Studies of Gastric Cancer.".Frontiers in oncology 12.(2022):898563